Natera Acquires Foresight Diagnostics in $450 Million Deal
Transaction expands Natera’s solid tumor MRD capabilities and adds ultrasensitive phased variant technology with detection below 0.1 parts per million.
Read More
Search Results for: lung cancer
Blood Test May Match CT for Early Lung Cancer Detection
The Mercy Halo test demonstrates performance similar to low-dose CT screening with the potential to reach underscreened populations.
Read More
New Data Shows How Plasma Detect Assay May Support Cancer Treatment Decisions
Research demonstrates the MRD assay’s utility in tracking disease progression and predicting treatment outcomes.
Read More
Lunit, Labcorp Partner on AI-Powered Digital Pathology Research
The collaboration combines Labcorp’s clinical expertise with Lunit’s AI algorithms to analyze tumor microenvironments and enhance biomarker discovery.
Read MoreAI Diagnostic Applications Showcased at AMP 2025 Annual Meeting
Studies demonstrate artificial intelligence achieving 93% cancer diagnostic accuracy and enabling noninvasive tumor analysis through spinal fluid testing.
Read More